Search results
PROMOTED
Author(s):
Nicolas M Van Mieghem
,
Kendra J Grubb
,
David Hildick-Smith
,
et al
Start date:
Mar 26, 2024
Author(s):
Helen Routledge
Added:
3 years ago
The preferred treatment approach for bifurcation disease can be generally summed up as ‘keep it simple’, otherwise known as provisional stenting. Based on several contemporary studies, coronary interventionalists have settled on a minimalist approach: starting with a single-stent approach for the main vessel (MV) and ignoring side branch (SB) disease unless clinical circumstances warrant…
View more
Author(s):
Yves Louvard
,
Marie-Claude Morice
,
Thomas Hovasse
,
et al
Added:
3 years ago
Due to anatomical reasons and the distributive function of the coronary tree, bifurcation sites are prone to the development of atherosclerotic lesions as a result of flow turbulence generating pro-atherogenous low wall shear stress (WSS). Over the past few years, coronary bifurcation lesions have been the subject of intense therapeutic discussions fuelled by new definitions, classifications …
View more
Author(s):
J Raider Estrada
,
Jonathan D Paul
,
Atman P Shah
,
et al
Added:
3 years ago
While the breadth of procedural offerings in interventional cardiology (IC) has exponentially expanded over the past four decades to include cardiac structural, peripheral arterial, and venous interventions, percutaneous coronary intervention (PCI) remains at the core of the field, accounting for the greatest percentage of therapeutic catheter-based procedures performed by IC practitioners in the…
View more
Treatment of Bifurcation Coronary Artery Disease with the Dedicated Cappella Sideguard® Stent
Author(s):
Mamas A Mamas
,
Farzin Fath-Ordoubadi
Added:
3 years ago
Article
Author(s):
Inga Narbute
,
Sanda Jegere
,
Indulis Kumsars
,
et al
Added:
3 years ago
Coronary bifurcation disease is present in up to 15–20 % of lesions undergoing percutaneous coronary intervention (PCI) and remains one of the outstanding challenges of treatment with PCI.1,2 PCI for coronary bifurcations is associated with more procedural complications and higher restenosis and adverse event rates than lesions in the body of the vessel.3–7 The introduction of drug-eluting stents…
View more
Author(s):
Inga Narbute
,
Sanda Jegere
,
Indulis Kumsars
,
et al
Added:
3 years ago
Abstract
Together with calcified lesions, saphenous vein grafts, chronic total occlusions and unprotected left main lesions, bifurcation lesions are complex lesions that remain among the outstanding challenges of treatment with percutaneous coronary intervention. Bifurcation lesions are associated with increased rates of procedural complications, restenosis and adverse events than lesions in the…
View more
Author(s):
David Hildick-Smith
Added:
11 months ago
EuroPCR 23 - Join us as we discover the latest findings from a three-year follow-up of the EBC MAIN Trial, as we interview Principal Investigator Dr David Hildick-Smith (Brighton and Sussex University Hospitals, UK) onsite at EuroPCR 23.
The EBC Main Trial aimed to investigate the outcomes of single-stent versus dual-stent bifurcation treatment of distal left main coronary artery lesions. This…
View more
Author(s):
Nicolas Foin
,
Eduardo Alegria-Barrero
,
Ryo Torii
,
et al
Added:
3 years ago
Drug-eluting stents (DESs) have contributed to a significant lowering of the incidence of restenosis and target vessel revascularisation (TVR) in bifurcations.1–4 A randomised study of bifurcation lesions using sirolimus-eluting stents revealed restenosis rates of only 4 % in the main branch (MB) and a TVR rate as low as 8.2 % at six-month follow-up,2 a marked improvement over that in historical…
View more
Stenting of Hypoplastic Aortic Segments with Mild Pressure Gradients and Arterial Hypertension
Author(s):
Derize E Boshoff
,
Werner Budts
,
Marc Gewillig
Added:
3 years ago
Article